A phase II trial of temsirolimus and bevacizumab in patients with endometrial, ovarian, hepatocellular carcinoma, carcinoid, or islet cell cancer: Ovarian cancer (OC) subset—A study of the Princess Margaret, Mayo, Southeast phase II, and California Cancer (CCCP) N01 Consortia NCI#8233.
R. Morgan
No relevant relationships to disclose
A. M. Oza
No relevant relationships to disclose
R. Qin
No relevant relationships to disclose
K. M. Laumann
No relevant relationships to disclose
H. Mackay
No relevant relationships to disclose
E. L. Strevel
No relevant relationships to disclose
S. Welch
No relevant relationships to disclose
D. Sullivan
No relevant relationships to disclose
R. M. Wenham
No relevant relationships to disclose
H. X. Chen
No relevant relationships to disclose
L. A. Doyle
No relevant relationships to disclose
D. R. Gandara
No relevant relationships to disclose
C. Erlichman
No relevant relationships to disclose